INTRODUCTION
Platelet-derived growth factor (PDGF)' is a 32,000-D polypeptide that is a potent mitogenic agent for fibroReceived for publication 3 January 1983 and in revised form 27 July 1983. 1 Abbreviations used in this paper: C5fr; chemotactic fragments of the fifth component of complement; FMLP, Nblasts, vascular smooth muscle cells, and glial cells. After PDGF is released from the alpha granules of activated platelets, it presumably acts locally to stimulate the growth of vascular smooth muscle cells and fibroblasts, thereby playing a role in wound healing and atherogenesis (1) . The mitogenic effect of PDGF on fibroblasts is initiated by its interaction with a specific 165,000-D receptor, which has been labeled by affinity cross-linking of '25I-PDGF to the cell membranes of 3T3 fibroblasts (2) . Reduction of native PDGF yields at least two polypeptides that are not capable of stimulating DNA synthesis (3, 4) .
In addition to its mitogenic activity, PDGF also has the ability to stimulate chemotaxis of human neutrophils and monocytes (5) , an effect that may be important in the inflammatory response at sites of thrombosis. Neither the mechanism by which PDGF stimulates leukocyte chemotaxis nor the relationship of this effect to the mitogenic effect of PDGF has been elucidated. Since a distinctive feature of the mitogenic response to PDGF is the loss of biological activity after reduction of PDGF, we have studied the ability of native and reduced PDGF to stimulate chemotaxis of leukocytes. The results, which indicate that reduced PDGF retains its activity as a chemotactic agent, suggest that the chemotactic response and mitogenic response are mediated by different structural determinants.
METHODS
Preparation of PDGF. PDGF was purified from human platelets essentially as described in reference 4. Platelet exformyl-methionyl-leucyl-phenylalanine; PDGF, platelet-derived growth factor. tracts were subjected to ion-exchange chromatography on carboxymethyl Sephadex, absorption chromatography using Blue Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ), and gel filtration using Biogel P-150. In some preparations, low molecular weight contaminants were present after these steps and were removed by high-pressure liquid chromatography using a phenyl micro Bondapack column (Waters Associates, Millipore Corp (6, 7) . After a 45-min and 90-min incubation at 37°C for neutrophils and monocytes, respectively, the filters were washed, fixed, and stained. The leukocytes were counted as described (6, 7) and chemotaxis was expressed as rret leukocytes per high-power field after subtraction of the corresponding value for filters of control chambers lacking a stimulus. Chemotactic fragments of the fifth component of complement (C5fr) were purified partially from zymosan-activated human serum (6) and synthetic Nformyl-methionyl-leucyl-phenylalanine (FMLP) was purchased from Sigma Chemical Co., St. Louis, MO.
Assessment of neutrophil lysosomal degranulation. Replicate suspensions of 2 X 106 neutrophils or mononuclear leukocytes in 1 ml of Hanks' solution-0.1 g human serum albumin/100 ml containing 0.5 mg of cytochalasin B/100 ml were incubated for 20 min at 37°C without and with PDGF or other stimuli and then centrifuged at 1,000 g for 5 min at 4°C. 20 ul each of the 1,000-g supernate and of a sonicate of the leukocyte pellet in 1 ml of release buffer were mixed separately with 75 ul of Hanks' solution and added to 0.9 ml of a solution of 0. ( Fig. 3 A) . The maximal response to both PDGF and reduced PDGF was consistently somewhat less than the maximal response to i0' M FMLP and C5fr, which are known potent chemotactic agents for neutrophils (9) . Reduced PDGF was at least as effective as native PDGF in evoking monocyte chemotaxis (Fig. 3 B) and caused a maximal response comparable to the maximal response to C5fr. To eliminate the possibility that the reduced polypeptide chains were recombining to form native PDGF during the incubations for the chemotaxis assay, the reduced preparations were alkylated with iodoacetamide to prevent disulfide formation. In each case, the same reduced preparations that failed to evoke fibroblast mitogenesis (Fig. 2) elicited optimal leukocyte chemotaxis (Fig. 3) Native PDGF stimulated the release of the lysosomal enzyme, f-glucosaminidase, from human neutrophils (Fig. 4) . The peak response elicited by PDGF was only about half of the peak response that could be elicited by 10-7 FMLP (Fig. 4) . Reduced PDGF stimulated #-glucosaminidase release over the same concentration range required for the release of the enzyme by native PDGF (0.03-1 nM). However, the maximal release attainable using reduced PDGF was less than the maximal release induced by native PDGF.
DISCUSSION
These results demonstrate that the polypeptides generated by reduction of PDGF have full activity as chemotactic agents but are devoid of activity as mitogens. Thus, the structural requirements for the interaction of PDGF with fibroblasts in eliciting a mitogenic response are different from those that are important for the interaction of PDGF with leukocytes in stimulating chemotaxis. Apparently, a single polypeptide chain of PDGF contains the structural information necessary for stimulating a chemotactic response, whereas at least two interconnected polypeptides are required for the mitogenic response. Our preliminary data, using PDGF polypeptide chains separated by SDS-polyacrylamide gel electrophoresis, lead us to suggest that the highPlatelet-derived Growth Factor Chemotactic Structural Determinants Fig. 4 indicate that PDGF stimulates the release of lysosomal enzymes from neutrophils. Reduced PDGF shared equal potency with native PDGF in this respect. However, both native and reduced PDGF achieved less than half the degree of enzyme release that could be stimulated by a maximal concentration of FMLP (Fig. 4) (Fig. 4) . However, the maximal response of reduced PDGF in stimulating lysosomal enzyme release was not as great as the maximal response of native PDGF in stimulating enzyme release. This is in contrast with the ability of reduced PDGF to stimulate chemotaxis to the same extent as native PDGF (Fig. 3) .
These findings raise the possibility that the sequence of steps between receptor binding and intracellular response is different for chemotaxis and lysosomal enzyme release. Thus, the interaction of reduced PDGF with the leukocyte cell surface might effectively trigger the events that lead to chemotaxis but only partially activate the sequence of steps leading to lysosomal enzyme release. Alternatively, it is possible that different receptor sites or different states of the same sites mediate chemotaxis and lysosomal enzyme release. Reduced PDGF may bind to both states but fully activate only the receptor state that is coupled to the chemotactic response. Additional work will be necessary to resolve these issues and to determine whether the stimulation of lysosomal enzyme release is important in vivo in the inflammatory response at sites of platelet aggregation and thrombus formation.
The mechanism by which PDGF initiates mitogenesis is unknown. Recent studies (11, 12) have demonstrated that one of the early steps after binding of PDGF to its receptor is the stimulation of a protein kinase that specifically phosphorylates tyrosine residues of a 170,000-D membrane protein, which may be the PDGF receptor. Whether a similar reaction is associated with the action of PDGF on leukocytes remains to be determined. It is likely that the chemotactic effect of PDGF on leukocytes is mediated by an interaction of PDGF with specific sites on the leukocyte membrane.
Further studies should elucidate the nature of the sites through which PDGF acts to elicit chemotaxis and should determine the relationship, if any, of these sites to the PDGF receptors that mediate the fibroblast mitogenic response.
